Veradigm (NASDAQ:MDRX) Shares Down 9.4% – Here’s What Happened

Veradigm Inc. (NASDAQ:MDRXGet Free Report)’s share price dropped 9.4% during trading on Monday . The company traded as low as $4.53 and last traded at $4.53. Approximately 846 shares were traded during mid-day trading, a decline of 100% from the average daily volume of 171,769 shares. The stock had previously closed at $5.00.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded Veradigm to a “hold” rating in a research report on Saturday, March 7th.

Read Our Latest Analysis on MDRX

Veradigm Stock Down 8.5%

The stock has a market capitalization of $551.13 million, a PE ratio of 23.25 and a beta of 0.55. The company has a 50-day moving average of $4.62 and a 200 day moving average of $4.65.

Veradigm Company Profile

(Get Free Report)

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.

Featured Articles

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.